Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS.
Hepatology. 2013 Dec;58(6):2099-108. doi: 10.1002/hep.26547. Epub 2013 Oct 11.
Acetaminophen (APAP) overdose is a major cause of hepatotoxicity and acute liver failure in the U.S., but the pathophysiology is incompletely understood. Despite evidence for apoptotic signaling, hepatic cell death after APAP is generally considered necrotic in mice and in humans. Recent findings suggest that the receptor interacting protein kinase 3 (RIP3) acts as a switch from apoptosis to necrosis (programmed necrosis). Thus, the aim of the current investigation was to determine if RIP3 is involved in APAP-induced liver cell death. APAP (200-300 mg/kg) caused glutathione depletion and protein adduct formation, oxidant stress, mitochondrial release of apoptosis inducing factor, and nuclear DNA fragmentation resulting in centrilobular necrosis in C57Bl/6J mice. Inhibiting RIP3 protein induction with antisense morpholinos in wild-type animals or using RIP3-deficient mice had no effect on protein adduct formation but attenuated all other parameters, including necrotic cell death, at 6 hours after APAP. In addition, cultured hepatocytes from RIP3-deficient mice showed reduced injury compared to wild-type cells after 24 hours. Interestingly, APAP-induced mitochondrial translocation of dynamin-related protein 1 (Drp1), the initiator of mitochondrial fission, was inhibited by reduced RIP3 protein expression and the Drp1 inhibitor MDIVI reduced APAP-induced cell death at 24 hours. All of these protective effects were lost after 24 hours in vivo or 48 hours in vitro.
RIP3 is an early mediator of APAP hepatotoxicity, involving modulation of mitochondrial dysfunction and oxidant stress. Controlling RIP3 expression could be a promising new approach to reduce APAP-induced liver injury, but requires complementary strategies to control mitochondrial dysfunction for long-term protection.
在美国,对乙酰氨基酚(APAP)过量是肝毒性和急性肝衰竭的主要原因,但病理生理学尚不完全清楚。尽管有凋亡信号的证据,但在小鼠和人类中,APAP 后肝细胞死亡通常被认为是坏死性的。最近的研究结果表明,受体相互作用蛋白激酶 3(RIP3)作为从凋亡到坏死(程序性坏死)的转换开关。因此,目前的研究旨在确定 RIP3 是否参与 APAP 诱导的肝细胞死亡。APAP(200-300mg/kg)导致谷胱甘肽耗竭和蛋白加合物形成、氧化应激、凋亡诱导因子的线粒体释放以及核 DNA 片段化,导致 C57Bl/6J 小鼠的中央小叶坏死。在野生型动物中用反义形态发生素抑制 RIP3 蛋白诱导或使用 RIP3 缺陷型小鼠对蛋白加合物形成没有影响,但在 APAP 后 6 小时减弱了所有其他参数,包括坏死性细胞死亡。此外,与野生型细胞相比,RIP3 缺陷型小鼠的培养肝细胞在 24 小时后显示出减少的损伤。有趣的是,APAP 诱导的动力相关蛋白 1(Drp1)的线粒体易位,线粒体裂变的启动子,通过减少 RIP3 蛋白表达和 Drp1 抑制剂 MDIVI 抑制,在 24 小时时减少了 APAP 诱导的细胞死亡。这些保护作用在体内 24 小时或体外 48 小时后均消失。
RIP3 是 APAP 肝毒性的早期介质,涉及调节线粒体功能障碍和氧化应激。控制 RIP3 表达可能是减少 APAP 诱导肝损伤的一种有前途的新方法,但需要补充控制线粒体功能障碍的策略以实现长期保护。